Last reviewed · How we verify
NCT07424313
The Low FODMAP Diet in Individuals With Small Intestinal Bacterial Overgrowth (SIBO)
NA trial testing Low FODMAP Diet in SIBO in 51 participants. Completed in 15 January 2026.
18 September 2025
Quick facts
| Lead sponsor | Warsaw University of Life Sciences |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 51 |
| Start date | 8 February 2024 |
| Primary completion | 18 September 2025 |
| Estimated completion | 15 January 2026 |
| Sites | 1 location across Poland |
Drugs / interventions tested
- Low FODMAP Diet
- Healthy Eating Diet
Conditions studied
- SIBO — all drugs for SIBO →
- Small Intestinal Bacterial Overgrowth — all drugs for Small Intestinal Bacterial Overgrowth →
- Small Intestinal Bacterial Overgrowth Syndrome (SIBO) — all drugs for Small Intestinal Bacterial Overgrowth Syndrome (SIBO) →
Sponsor
Warsaw University of Life Sciences
Who can join
18 and older, any sex, with SIBO or Small Intestinal Bacterial Overgrowth. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study aims to assess the impact of a low FODMAP diet (LFD) on gastrointestinal symptoms and nutritional status in individuals diagnosed with small intestinal bacterial overgrowth (SIBO). Participants were randomly assigned to either an intervention group or a control group following completion of antibiotic therapy. The intervention group followed a LFD, while the control group followed a normal diet, in accordance with the principles of rational nutrition. Gastrointestinal symptoms, nutritional status, and quality of life were assessed using questionnaires, dietary records, anthropometric measurements, and blood biochemical parameters.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT07424313
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Low FODMAP Diet
Trials testing the same drug.
- NCT06871748 — Effect of a Low FODMAP Diet in IBS and Functional Constipation with Bloating: a Randomized Double-Blind Trial · NA · not yet recruiting
- NCT04640155 — Treating Chronic Pouchitis With a Low FODMAP Diet · NA · withdrawn
- NCT03823742 — Do Biomarkers Predict Response to a Pediatric Chronic Pain Symptom Management Program? · NA · completed
- NCT03219528 — A Longitudinal Study to Identify IBS Phenotypes Using Fecal Microbiota and Hydrogen Breath Testing · Phase 4 · completed
- NCT04543474 — Treatment Efficacy of Low FODMAP Versus Low Lactose Diet in IBS Patients · NA · completed
Other recruiting trials for SIBO
Currently open trials in the same condition.
- NCT06772064 — Efficacy of Rifaximin in Patients With Small Intestinal Bacterial Overgrowth Presenting With Abdominal Bloating. · NA · recruiting
- NCT04418258 — Capillary Endoscopy Aspiration Catheter · NA · recruiting
Other Warsaw University of Life Sciences trials
Trials by the same sponsor.
- NCT03811197 — Efficacy of Diet and Hypnotic Suggestions or Telemedicine in Obesity Management · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07424313 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Warsaw University of Life Sciences
- Last refreshed: 24 February 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07424313.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing